Skip to content
healthcare.dev

Pramipexole Dihydrochloride Extended-Release

NDC 71034-003, Pramipexole Dihydrochloride, tablet, extended release, from Xiamen LP Pharmaceutical Co., Ltd..

Product NDC
71034-003
Status
Listed
Labeler
Xiamen LP Pharmaceutical Co., Ltd.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212797
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71034-003 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PRAMIPEXOLE DIHYDROCHLORIDE.75 mg/1

Pharmacologic classes

Dopamine Agonists [MoA]; Nonergot Dopamine Agonist [EPC]

Package NDCNDC-11Package
71034-003-307103400033030 TABLET, EXTENDED RELEASE in 1 BOTTLE (71034-003-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1cbd8ddf-4fc1-4cd0-906d-a55a4b8b1c3c

Use it

Look up 71034-003 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71034-003 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71034-003. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.